158 related articles for article (PubMed ID: 1824983)
21. Thymic selection process induced by hybrid antibodies.
Zepp F; Staerz UD
Nature; 1988 Dec; 336(6198):473-5. PubMed ID: 3057386
[TBL] [Abstract][Full Text] [Related]
22. Efficiency of antigen presentation after antigen targeting to surface IgD, IgM, MHC, Fc gamma RII, and B220 molecules on murine splenic B cells.
Snider DP; Segal DM
J Immunol; 1989 Jul; 143(1):59-65. PubMed ID: 2471743
[TBL] [Abstract][Full Text] [Related]
23. Functionally anergic lpr and gld B220+ T cell receptor (TCR)-alpha/beta+ double-negative T cells express CD28 and respond to costimulation with phorbol myristate acetate and antibodies to CD28 and the TCR.
Giese T; Allison JP; Davidson WF
J Immunol; 1993 Jul; 151(2):597-609. PubMed ID: 7687618
[TBL] [Abstract][Full Text] [Related]
24. T-cell activation. I. Evidence for a functional linkage between class I MHC antigens and the Tc-Ti complex.
Brams P; Claesson MH
Immunology; 1989 Mar; 66(3):348-53. PubMed ID: 2522906
[TBL] [Abstract][Full Text] [Related]
25. Antibodies to common leukocyte antigen p220 influence human T cell proliferation by modifying IL 2 receptor expression.
Ledbetter JA; Rose LM; Spooner CE; Beatty PG; Martin PJ; Clark EA
J Immunol; 1985 Sep; 135(3):1819-25. PubMed ID: 3160781
[TBL] [Abstract][Full Text] [Related]
26. Different CD45 and CD45R epitopes involved in T cell proliferation and NK cytotoxicity.
Ruiz-Cabello F; Huelin C; Pedrinaci S; Lopez Nevot MA; Garrido F
Hybridoma; 1989 Feb; 8(1):1-11. PubMed ID: 2466763
[TBL] [Abstract][Full Text] [Related]
27. Amplification of T-cell blastogenic responses in healthy individuals and patients with acquired immunodeficiency syndrome.
Dis Markers; 1990; 8(4):223-4. PubMed ID: 2150930
[No Abstract] [Full Text] [Related]
28. Prolonged expression of high molecular mass CD45RA isoform during the differentiation of human progenitor thymocytes to CD3+ cells in vitro.
Deans JP; Wilkins JA; Caixia S; Pruski E; Pilarski LM
J Immunol; 1991 Dec; 147(12):4060-8. PubMed ID: 1836475
[TBL] [Abstract][Full Text] [Related]
29. The role of L3T4 in T cell activation: L3T4 may be both an Ia-binding protein and a receptor that transduces a negative signal.
Tite JP; Sloan A; Janeway CA
J Mol Cell Immunol; 1986; 2(4):179-90. PubMed ID: 3509916
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of T cell activation by a monoclonal antibody reactive against the alpha 3 domain of human MHC class I molecules.
Smith DM; Bluestone JA; Jeyarajah DR; Newberg MH; Engelhard VH; Thistlethwaite JR; Woodle ES
J Immunol; 1994 Aug; 153(3):1054-67. PubMed ID: 7913109
[TBL] [Abstract][Full Text] [Related]
31. Treatment of murine B cell lymphoma with bispecific monoclonal antibodies (anti-idiotype x anti-CD3).
Demanet C; Brissinck J; Van Mechelen M; Leo O; Thielemans K
J Immunol; 1991 Aug; 147(3):1091-7. PubMed ID: 1830596
[TBL] [Abstract][Full Text] [Related]
32. Monoclonal antibodies to murine CD3 epsilon define distinct epitopes, one of which may interact with CD4 during T cell activation.
Portoles P; Rojo J; Golby A; Bonneville M; Gromkowski S; Greenbaum L; Janeway CA; Murphy DB; Bottomly K
J Immunol; 1989 Jun; 142(12):4169-75. PubMed ID: 2470817
[TBL] [Abstract][Full Text] [Related]
33. Expression of a 33-kDa antigen Tm 1 on lymphocyte surface after modulation of cell surface antigens by IgM monoclonal antibody.
Hara T; Jung LK; Fu SM
J Immunol; 1988 Feb; 140(4):1028-33. PubMed ID: 2963858
[TBL] [Abstract][Full Text] [Related]
34. Stimulation of murine T cell subsets with anti-CD3 antibody. Age-related defects in the expression of early activation molecules.
Ernst DN; Weigle WO; McQuitty DN; Rothermel AL; Hobbs MV
J Immunol; 1989 Mar; 142(5):1413-21. PubMed ID: 2521878
[TBL] [Abstract][Full Text] [Related]
35. Two roles for Ia in antigen-specific T lymphocyte activation.
Kim KH; Shivdasani RA; Thomas DW
J Immunol; 1986 Dec; 137(11):3393-400. PubMed ID: 3491135
[TBL] [Abstract][Full Text] [Related]
36. T-cell activation and lymphokine production induced by antihuman CD3 monoclonal antibodies.
Woodle ES; Thistlethwaite JR; Jolliffe LK; Ghobrial I; Fuccello AJ; Stuart FP; Bluestone JA
Transplant Proc; 1991 Feb; 23(1 Pt 1):81-2. PubMed ID: 1824999
[No Abstract] [Full Text] [Related]
37. Phenotypic changes associated with activation of CD45RA+ and CD45RO+ T cells.
Wallace DL; Beverley PC
Immunology; 1990 Mar; 69(3):460-7. PubMed ID: 1968889
[TBL] [Abstract][Full Text] [Related]
38. Antibodies against the CD44 p80, lymphocyte homing receptor molecule augment human peripheral blood T cell activation.
Denning SM; Le PT; Singer KH; Haynes BF
J Immunol; 1990 Jan; 144(1):7-15. PubMed ID: 1967267
[TBL] [Abstract][Full Text] [Related]
39. Cross-linking of Lyt-2 (CD8) to the T cell antigen receptor optimally activates T lymphocytes.
Boyce NW; Eichmann K
Transplant Proc; 1989 Feb; 21(1 Pt 1):133-7. PubMed ID: 2495596
[No Abstract] [Full Text] [Related]
40. T8 cell regulation of human B cell responsiveness: regulatory influences of CD45RA+ and CD45RA- T8 cell subsets.
Hirohata S
Cell Immunol; 1991 Mar; 133(1):15-26. PubMed ID: 1825031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
